Watch Ticker

Mersana Therapeutics, Inc. Common Stock

Go to Mersana Therapeutics, Inc. Common Stock Website

$6.79

-0.25 (-3.48%)

Live

Previous Close

$7.04

Day Range

$6.7609 - $7

Previous Day Range

$6.74 - $7.05

Market Cap

$34.2 million USD

Day Vol.

16154

Previous Day Vol.

80501

Currency

USD

Primary Exchange

Nasdaq

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Mersana Therapeutics - Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025

Mersana Therapeutics will report Q2 2025 financial results on August 13, 2025, and host a conference call. The company is developing antibody-drug conjugates (ADCs) for cancer treatment, with promising interim Phase 1 clinical data for their Emi-Le drug candidate.

Related tickers: MRSN.

Read Full Article

Mersana Therapeutics - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

Mersana Therapeutics announced a strategic restructuring and reprioritization plan to focus on advancing its Emi-Le drug candidate for triple-negative breast cancer. The company reported updated clinical data for Emi-Le and plans to report initial expansion data in the second half of 2025.

Related tickers: MRSN.

Read Full Article

Trending Tickers

Please sign in to view